Cyanidin

Cyanidin is a naturally occurring anthocyanin pigment found in berries, red cabbage, and cherries that exerts antioxidant and anti-inflammatory effects primarily by scavenging reactive oxygen species and inhibiting NF-κB signaling. It demonstrates gastroprotective and blood sugar-regulating properties in preclinical models, though robust human clinical trial data remains limited.

Category: Compound Evidence: 4/10 Tier: Preliminary (in-vitro/animal)
Cyanidin — Hermetica Encyclopedia

Origin & History

Cyanidin is a water-soluble anthocyanin pigment responsible for red, blue, and purple colors in fruits like blackberries, blueberries, cherries, and red grapes. It is typically extracted using acidified methanol or ethanol solvents, followed by chromatographic purification to isolate cyanidin or its glycosides like cyanidin-3-glucoside (C3G).

Historical & Cultural Context

While isolated cyanidin has no specific traditional use, berries rich in cyanidin like elderberry and bilberry have been used in European herbalism since the 16th century for gastrointestinal issues and inflammation. The compound was not identified as the active constituent until modern phytochemical analysis.

Health Benefits

• Gastroprotection: Reduced peptic ulcer lesions by 80-93% at 20mg/kg in mouse models (preclinical evidence only) • Blood sugar regulation: Improved serum glucose in 87.5% of diabetic animal studies reviewed (no human trials) • Anti-inflammatory effects: Suppressed inflammatory markers TNF-α, IL-1β, IL-6 in arthritis mouse models (preclinical) • Antioxidant activity: Decreased lipid peroxidation and boosted antioxidant defenses in animal studies (preclinical) • Potential anticancer properties: Induced apoptosis in prostate/breast cancer cells via caspase-3 activation (in-vitro only)

How It Works

Cyanidin inhibits the NF-κB transcription factor pathway, thereby suppressing downstream pro-inflammatory cytokines including TNF-α and IL-1β at the gene expression level. It scavenges reactive oxygen species through its catechol B-ring structure, donating hydrogen atoms to neutralize free radicals and chelating transition metal ions that catalyze oxidative reactions. Additionally, cyanidin modulates GLUT4 translocation and may inhibit α-glucosidase enzyme activity, contributing to its observed effects on postprandial glucose regulation in animal models.

Scientific Research

Clinical evidence for cyanidin is limited to preclinical studies, with no large-scale human RCTs identified. A systematic review of 16 animal studies found C3G reduced serum glucose in diabetic rodents (PMID: 41371544), while berry-rich diet reviews linked anthocyanins to disease prevention but lacked cyanidin-specific human trials (PMID: 33740221).

Clinical Summary

The majority of cyanidin research consists of in vitro cell studies and rodent models, with very few randomized controlled trials in humans isolating cyanidin specifically rather than mixed anthocyanin extracts. In mouse models, oral administration of cyanidin at 20 mg/kg reduced peptic ulcer lesions by 80–93%, and a review of diabetic animal studies found improved serum glucose outcomes in approximately 87.5% of trials examined. Anti-inflammatory endpoints including reductions in TNF-α and IL-1β have been replicated across multiple preclinical studies, but direct translation to human dosing and efficacy is not yet established. Consumers should treat all current health benefit claims as preliminary pending adequately powered human clinical trials.

Nutritional Profile

Cyanidin is a pure polyphenolic compound (anthocyanidin class), not a whole food, so it contains no macronutrients, fiber, or conventional micronutrients. Molecular formula: C15H11O6+ (flavylium cation form); molecular weight: 287.24 g/mol. It is the aglycone (sugar-free) core found in cyanidin-3-glucoside (C3G), cyanidin-3-rutinoside, and cyanidin-3,5-diglucoside glycoside forms. Typical concentrations in food sources: black elderberry (~1,000–4,000 mg/kg fresh weight as glycosides), black chokeberry (aronia) (~2,000–3,000 mg/kg), black currant (~1,300–2,000 mg/kg), red cabbage (~250–700 mg/kg), and sweet cherries (~50–270 mg/kg). Bioavailability is notably low and variable: oral bioavailability estimated at 0.1–1.8% in human studies, with peak plasma concentrations (Cmax) of ~1–10 nmol/L after typical dietary intake. Absorption occurs primarily in the stomach and small intestine via SGLT1 and bilitranslocase transporters. Rapid metabolism occurs in intestinal epithelium and liver, producing protocatechuic acid and phloroglucinaldehyde as primary degradation products, which may contribute to bioactivity. Half-life is approximately 1.5–2 hours post-absorption. The glycoside form (C3G) demonstrates slightly improved stability and absorption compared to free cyanidin aglycone. No protein, fat, carbohydrate, or caloric content attributable to cyanidin itself as an isolated compound.

Preparation & Dosage

No clinically studied human dosages exist. Preclinical studies used 5-20 mg/kg cyanidin chloride in mice. Berry extracts standardized to 1-10% cyanidins are typically dosed at 50-500 mg/day in dietary studies, though specific standardization details are lacking. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Quercetin, Vitamin C, Resveratrol, Bilberry Extract, Grape Seed Extract

Safety & Interactions

Cyanidin consumed through whole food sources such as berries is generally recognized as safe, and no serious adverse events have been reported in short-term human studies using anthocyanin-rich extracts. At pharmacological doses used in animal studies (10–50 mg/kg), no overt toxicity was observed, but equivalent human doses have not been formally safety-tested in clinical trials. Cyanidin may theoretically potentiate the effects of antidiabetic medications such as metformin or insulin due to its glucose-lowering activity, warranting caution and physician consultation in diabetic patients. Safety data during pregnancy and lactation is insufficient, and use of concentrated cyanidin supplements should be avoided in these populations until further evidence is available.